Pricing Log in Create free account

Candel Therapeutics, Inc. (CADL) vs Janux Therapeutics, Inc. (JANX)

Candel Therapeutics, Inc. and Janux Therapeutics, Inc. are both Biotechnology companies. Candel Therapeutics, Inc. and Janux Therapeutics, Inc. are of similar size ($758.1M and $705.5M). Janux Therapeutics, Inc. grew revenue faster over the last twelve months: 214.4% against 0.00%. Candel Therapeutics, Inc. has the higher net margin (0.00% vs −300.0%) and the higher return on invested capital (0.00% vs 0.00%). Across the 16 metrics below, Janux Therapeutics, Inc. leads on 11 and Candel Therapeutics, Inc. on 5.

Valuation

Metric CADL JANX Biotechnology median
P/E n/m n/m 11.58
P/S 5,473.85 23.60 9.61
P/B 5.42 0.86 2.26
Price to free cash flow n/m n/m 26.41
EV/EBITDA n/m 1.07 0.72
EV/Sales 4,277.78 (4.81) 9.43
Earnings yield (15.28%) (12.77%) (32.28%)
Free cash flow yield (8.37%) (6.90%) (22.27%)

Profitability

Metric CADL JANX Biotechnology median
Gross margin 0.00% 100.00% 68.81%
Operating margin 0.00% (419.24%) 0.00%
Net margin 0.00% (299.95%) 0.00%
Free cash flow margin 0.00% (162.70%) 0.00%
Return on equity (81.84%) (10.58%) (50.30%)
Return on assets (56.37%) (9.94%) (45.47%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric CADL JANX Biotechnology median
Revenue growth (TTM) 0.00% 214.40% 6.78%
EPS growth (last fiscal year) 58.62% (42.97%) 29.88%
Revenue growth, 5-year CAGR — — 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric CADL JANX Biotechnology median
Debt to equity 0.38 0.00 0.00
Current ratio 16.09 17.69 4.74
Net debt to EBITDA 1.53 5.58 1.01

Dividend

Metric CADL JANX Biotechnology median
Dividend yield — — 0.39%
Payout ratio — — —

Size

Metric CADL JANX Biotechnology median
Market cap 705.50m 758.06m 168.63m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack